Penoliad, Evie A.

HRN: 20-75-65  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2022
CEFTRIAXONE 1G (VIAL)
12/10/2022
12/16/2022
IV
2gm
OD
DM Foot
Waiting Final Action 
12/10/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/10/2022
12/16/2022
IV
600mg
Q6
DM Foot
Waiting Final Action 
12/11/2022
CEFTAZIDIME 1GM (VIAL)
12/11/2022
12/18/2022
IV
2g
Q8
Diabetic Foot
Waiting Final Action 
12/18/2022
CEFIXIME 200MG (CAP)
12/18/2022
12/25/2022
PO
200mg
BID
Dm Foot
Waiting Final Action 
12/18/2022
CLINDAMYCIN 300MG (CAP)
12/18/2022
12/25/2022
PO
300mg
TID
Dm Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: